Geoffrey Shapiro, MD, PhD | Authors


Dr. Geoffrey Shapiro on the Role of CDK2 in Multiple Breast Cancer Types

January 26, 2016

Geoffrey Shapiro, MD, PhD, director, Early Drug Development Center, Dana Farber, discusses the role of cyclin-dependent kinase (CDK4) in some breast cancer subtypes and the lack of targeted agents in triple-negative breast cancer.